1. Home
  2. VYNE vs CTRM Comparison

VYNE vs CTRM Comparison

Compare VYNE & CTRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • CTRM
  • Stock Information
  • Founded
  • VYNE 2003
  • CTRM 2016
  • Country
  • VYNE United States
  • CTRM Cyprus
  • Employees
  • VYNE N/A
  • CTRM N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • CTRM Marine Transportation
  • Sector
  • VYNE Health Care
  • CTRM Consumer Discretionary
  • Exchange
  • VYNE Nasdaq
  • CTRM Nasdaq
  • Market Cap
  • VYNE 24.3M
  • CTRM 20.5M
  • IPO Year
  • VYNE 2018
  • CTRM N/A
  • Fundamental
  • Price
  • VYNE $0.35
  • CTRM $2.09
  • Analyst Decision
  • VYNE Buy
  • CTRM
  • Analyst Count
  • VYNE 2
  • CTRM 0
  • Target Price
  • VYNE $8.00
  • CTRM N/A
  • AVG Volume (30 Days)
  • VYNE 4.1M
  • CTRM 30.6K
  • Earning Date
  • VYNE 08-14-2025
  • CTRM 08-11-2025
  • Dividend Yield
  • VYNE N/A
  • CTRM N/A
  • EPS Growth
  • VYNE N/A
  • CTRM N/A
  • EPS
  • VYNE N/A
  • CTRM N/A
  • Revenue
  • VYNE $476,000.00
  • CTRM $66,197,291.00
  • Revenue This Year
  • VYNE $42.51
  • CTRM N/A
  • Revenue Next Year
  • VYNE N/A
  • CTRM N/A
  • P/E Ratio
  • VYNE N/A
  • CTRM N/A
  • Revenue Growth
  • VYNE N/A
  • CTRM N/A
  • 52 Week Low
  • VYNE $0.33
  • CTRM $1.98
  • 52 Week High
  • VYNE $4.30
  • CTRM $5.08
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 29.46
  • CTRM 35.44
  • Support Level
  • VYNE $0.35
  • CTRM $2.07
  • Resistance Level
  • VYNE $0.36
  • CTRM $2.14
  • Average True Range (ATR)
  • VYNE 0.04
  • CTRM 0.04
  • MACD
  • VYNE -0.02
  • CTRM -0.01
  • Stochastic Oscillator
  • VYNE 1.79
  • CTRM 9.52

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About CTRM Castor Maritime Inc.

Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.

Share on Social Networks: